[Assessment of proliferation: core biopsy or resection specimen? Discrepancies in breast cancer with low and high proliferation]

Obermann, E C; Eppenberger-Castori, S; Tapia, C (2012). [Assessment of proliferation: core biopsy or resection specimen? Discrepancies in breast cancer with low and high proliferation]. Pathologe, 33(3), pp. 245-50. Heidelberg: Springer-Verlag 10.1007/s00292-012-1583-y

[img]
Preview
Text
292_2012_Article_1583.pdf - Published Version
Available under License Publisher holds Copyright.

Download (706kB) | Preview

The assessment of the proliferation fraction is becoming more and more important; however, there is no consensus concerning optimal validation. Depending on the institute the proliferation fraction is determined either from a core biopsy (SB) or resection specimen (OP).

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Tapia, Coya

ISSN:

0172-8113

Publisher:

Springer-Verlag

Language:

German

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:32

Last Modified:

26 Oct 2020 16:57

Publisher DOI:

10.1007/s00292-012-1583-y

PubMed ID:

22576598

Web of Science ID:

000304107400009

BORIS DOI:

10.7892/boris.12450

URI:

https://boris.unibe.ch/id/eprint/12450 (FactScience: 218794)

Actions (login required)

Edit item Edit item
Provide Feedback